tiprankstipranks
Oncternal Therapeutics Inc (ONCT)
NASDAQ:ONCT
US Market

Oncternal Therapeutics (ONCT) Financial Statements

451 Followers

Oncternal Therapeutics Financial Overview

Oncternal Therapeutics's market cap is currently ―. The company's EPS TTM is $-12.342; its P/E ratio is -0.62; Oncternal Therapeutics is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-3.03. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue$ 569.00K$ 582.00K$ 179.00K$ 106.00K$ 203.00K
Gross Profit$ 569.00K$ 297.00K$ 179.00K$ 106.00K$ 203.00K
EBIT$ -8.78M-$ -10.39M$ -8.97M$ -11.49M
EBITDA$ -8.78M-$ -10.39M$ -9.43M$ -11.93M
Net Income Common Stockholders$ -8.39M$ -9.16M$ -9.86M$ -8.97M$ -11.49M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 27.03M$ 34.26M$ 40.30M$ 45.50M$ 54.32M
Total Assets$ 29.14M$ 36.73M$ 43.20M$ 50.77M$ 58.28M
Total Debt$ 278.00K$ 318.00K$ 342.00K$ 366.00K$ 50.00K
Net Debt$ -26.75M$ -33.94M$ -39.96M$ -45.14M$ -54.27M
Total Liabilities$ 6.21M$ 6.68M$ 6.20M$ 5.59M$ 5.79M
Stockholders Equity$ 22.89M$ 30.05M$ 37.00M$ 45.14M$ 52.48M
Cash Flow-
Free Cash Flow$ -7.44M$ -6.42M$ -5.51M$ -9.26M$ -10.97M
Operating Cash Flow$ -7.44M$ -6.42M$ -5.51M$ -9.26M$ -10.97M
Investing Cash Flow$ 7.22M$ -1.81M$ 4.66M$ 13.85M$ -16.05M
Financing Cash Flow$ -87.00K$ -1.00K$ -49.00K$ -1.00K$ 1.12M
Currency in USD

Oncternal Therapeutics Earnings and Revenue History

Oncternal Therapeutics Debt to Assets

Oncternal Therapeutics Cash Flow

Oncternal Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis